How will the pharma contract sales market perform from 2011? Visiongain's report shows you potential revenues and trends to 2021, discussing opportunities and prospects. 

Find revenue predictions for pharma contract sales services at total world, submarket and national levels. Our report gives you forecasts to 2021 for the world market and leading countries. Outsourced pharma sales activities will expand from 2011 to 2021.

Where's the market heading? See how emerging technologies are changing drug promotion and sales, and how service providers contribute value to pharmaceutical sales operations. Through our research and analysis we aim to save you time and help in your decisions.

How will changes in the pharma industry affect contract sales organisations (CSOs)? In our report you can see revenue predictions and discussions for outsourced field sales teams, non-personal promotion and other services. 

Assess leading companies: Quintiles, InVentiv Health, OnCall, PDI, Pharmexx, Publicis Touchpoint Solutions and United Drug. Outsourcing of pharma sales activities will become more important this decade. See opportunities for service providers and pharma companies.

Generics and biosimilars provide different challenges for pharmaceutical sales operations. Also, tele-detailing and e-detailing will become more important this decade, as will medical science liaison (MSL) and clinical education. Find outsourcing trends in our study.

Our report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. You can find answers now in our work.

Revenue forecasts, market shares, developmental trends, discussions and opinion

In our report you find revenue forecasts, growth rates and market shares. You also receive qualitative analyses, opinion from our survey and a review of companies. Discover 91 tables and charts and a research interview (see the table of contents).

Advantages of World Pharma Contract Sales Organisation (CSO) Market 2011-2021 for your work

Our report gives you the following advantages in particular:
• Discover revenue forecasts to 2021 for the overall world CSO market and submarkets, finding growth potential
• Receive revenue forecasts to 2021 for the US, Japan, the UK, Germany, France,Italy, Spain, India and China
• Investigate pharma contract sales for a range of applications, seeing trends including e-detailing, tele-detailing and customer relationship management (CRM)
• Find discussion of digital and virtual CSO services, including social media
• Assess leading companies in pharma contract sales, finding activities and outlooks
• See competition and opportunities that will influence pharma CSO revenues
• Find out what will stimulate and restrain the CSO industry and market from 2011, including regulatory trends
• View external opinion in an interview transcript from our survey.

There, you find a distinctive mix of quantitative and qualitative analysis with independent predictions. We tackle crucial questions on sales outsourcing, helping you to stay ahead.

Gain industry and market analysis for pharmaceutical sales outsourcing now

Our report is for everybody needing industry and market analysis for outsourced pharma sales activities. Find trends and answers. Avoid missing out - please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 
 
 

Table Of Contents

Table of Contents

1. Executive Summary
1.1 Pharmaceutical Contract Sales: Market Review
1.2 Chapter Breakdown
1.3 Research and Analysis Methods

2. Introduction to Pharmaceutical Contract Sales
2.1 Pharmaceutical Sales Models
2.1.1 Detailing
2.1.1.1 Sampling
2.1.2 Direct-to-Consumer (DTC) Marketing
2.1.3 The Patent Cliff
2.1.4 Pharmaceutical Sales Staff Reductions
2.1.5 Changes Required to the Sales Model
2.2 Pharmaceutical Outsourcing
2.3 Contract Sales Organisations (CSOs)
2.3.1 Key Services Provided by CSOs
2.3.1.1 Dedicated Sales Teams
2.3.1.2 Shared Sales Teams
2.3.1.3 Telesales and Non-Personal Promotion
2.3.1.4 Medical Science Liaison and Clinical Education
2.3.1.5 Personnel Recruitment and Training
2.3.2 Benefits to Outsourcing Pharmaceutical Sales

3. The Pharmaceutical Contract Sales Organisation Market 2011-2021
3.1 The Pharmaceutical Contract Sales Organisation Market in 2010
3.2 The Pharmaceutical Contract Sales Organisation Market: Overall Revenue Forecast 2011-2021
3.2.1 Contract Sales Organisations of the Future
3.2.2 CSO Subsector Market Shares 2011-2021
3.3 Outsourced Field Sales Teams Market 2010
3.3.1 Outsourced Field Sales Teams Market: Revenue Forecast 2011-2021
3.4 Non-Personal Promotion Services Market 2010
3.4.1 Non-Personal Promotion Services Market: Revenue Forecast 2011-2021
3.4.2 E-Detailing
3.5 Other CSO Services Market 2010
3.5.1 Other CSO Services Market: Revenue Forecast 2011-2021

4. Leading National Contract Sales Markets 2011-2021
4.1 Breakdown of the Global Pharmaceutical Contract Sales Market 2010
4.1.1 A Comparison of Pharmaceutical Sales in the US, Europe and Japan
4.2 Leading National Markets: Revenue Forecasts 2011-2021
4.2.1 The US: Revenues 2011-2021
4.2.2 The European Market: Revenues 2011-2021
4.2.2.1 European Contract Sales Market Forecasts 2011-2021
4.2.2.2 The UK: Revenues 2011-2021
4.2.2.3 Germany: Revenues 2011-2021
4.2.2.4 France: Revenues 2011-2021
4.2.2.5 Italy: Revenues 2011-2021
4.2.2.6 Spain: Revenues 2011-2021
4.2.3 Japan: Revenues 2011-2021
4.2.3.1 CMIC Group
4.2.4 China: Revenues 2011-2021
4.2.4.1 Invida Group
4.2.5 India: Revenues 2011-2021
4.2.5.1 FMRAI
4.3 Regional Regulatory Issues and Developments
4.3.1 US Bribery Concerns
4.3.2 US Healthcare Reform 2010
4.3.2.1 Physician Payment Sunshine Act
4.3.3 European Regulatory Developments
4.3.3.1 Direct-to-Consumer (DTC) Marketing
4.3.3.2 UK Bribery Act 2010
4.3.4 China

5. Leading Contract Sales Organisations in 2011
5.1 InVentiv Health
5.1.1 Recent Activity
5.1.2 Recent Industry Partnerships
5.2 OnCall
5.3 PDI
5.3.1 Expanded Services 2010-2011
5.3.1.1 Interpace BioPharma
5.3.2 Revenue and Recent Performance Analysis
5.3.2.1 Company Performance 2011
5.4 Pharmexx
5.4.1 Recent Performance Analysis
5.4.2 Indian Expansion
5.5 Publicis Touchpoint Solutions
5.5.1 Recent Industry Partnerships
5.6 Quintiles
5.6.1 Quintiles Sales Services
5.6.1.1 Expanded Services 2011
5.6.2 Recent Industry Partnerships
5.7 United Drug
5.7.1 Recent Performance and Future Directions
5.7.1.1 United Drug Acquires InforMed

6. Contract Sales Industry Trends 2011-2021
6.1 Strengths and Weaknesses in the Pharmaceutical Contract Sales Market, 2011
6.1.1 Risks and Benefits for Outsourcing Pharma Sales Operations 
6.2 Pharmaceutical Industry Trends Affecting the Contract Sales Market 2011-2021
6.2.1 The Popularity in Developing Specialty Drugs
6.2.2 Patent Expiries and Lifecycle Management
6.2.3 Generics and Biosimilars
6.2.4 Growth in the Asian Pharmaceutical Markets 
6.3 Opportunities and Threats in the Pharmaceutical Contract Sales Market, 2011-2021
6.4 Social Factors
6.4.1 Ethics in Pharmaceutical Sales
6.4.2 Ethics in US Pharmaceutical Sales
6.4.3

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.